Afasevikumab

Generic Name
Afasevikumab
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
1589503-30-9
Unique Ingredient Identifier
TG8A3DSU6Z
Background

Afasevikumab is under investigation in clinical trial NCT01480310 (Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers).

Associated Conditions
-
Associated Therapies
-

A Study of MCAF5352A in Healthy Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2012-02-29
Last Posted Date
2016-11-02
Lead Sponsor
Genentech, Inc.
Target Recruit Count
23
Registration Number
NCT01540760

Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-11-28
Last Posted Date
2016-11-02
Lead Sponsor
Genentech, Inc.
Target Recruit Count
23
Registration Number
NCT01480310
© Copyright 2024. All Rights Reserved by MedPath